Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Filamon LTD
Aminex Therapeutics, Inc.
Hoffmann-La Roche
Psyence Australia Pty Ltd
Eastern Cooperative Oncology Group
ViroMissile, Inc.
Hummingbird Bioscience
Replimune Inc.
Dana-Farber Cancer Institute
Kaiser Permanente
Mayo Clinic
University of Florida
Tizona Therapeutics, Inc
Essen Biotech
Essen Biotech
Wake Forest University Health Sciences
Sapience Therapeutics
MacroGenics
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Second Life Therapeutics
NRG Oncology
Fusion Pharmaceuticals Inc.
University of Southern California
The Netherlands Cancer Institute
OncoNano Medicine, Inc.
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Abramson Cancer Center at Penn Medicine
AstraZeneca
Bayer
Tempus AI
UNC Lineberger Comprehensive Cancer Center
Actym Therapeutics, Inc.
Virginia Commonwealth University
British Columbia Cancer Agency
Institut Curie
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Institut Cancerologie de l'Ouest
Milton S. Hershey Medical Center
University of Virginia
Duke University
Eli Lilly and Company
NRG Oncology
Shandong Boan Biotechnology Co., Ltd
Mayo Clinic